Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter Kraft, Ph.D.

Co-Author

This page shows the publications co-authored by Peter Kraft and Amit Joshi.
Connection Strength

2.265
  1. Obesity, Adiposity, and Risk of Symptomatic Gallstone Disease According to Genetic Susceptibility. Clin Gastroenterol Hepatol. 2021 Jul 02.
    View in: PubMed
    Score: 0.247
  2. Hierarchical modeling of melanocortin 1 receptor variants with skin cancer risk. Genet Epidemiol. 2018 09; 42(6):571-586.
    View in: PubMed
    Score: 0.200
  3. Evidence for large-scale gene-by-smoking interaction effects on pulmonary function. Int J Epidemiol. 2017 06 01; 46(3):894-904.
    View in: PubMed
    Score: 0.186
  4. Four Susceptibility Loci for Gallstone Disease Identified in a Meta-analysis of Genome-Wide Association Studies. Gastroenterology. 2016 Aug; 151(2):351-363.e28.
    View in: PubMed
    Score: 0.172
  5. Response to Day et al. Am J Hum Genet. 2016 Feb 04; 98(2):394-5.
    View in: PubMed
    Score: 0.169
  6. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Res Treat. 2016 Feb; 155(3):531-40.
    View in: PubMed
    Score: 0.169
  7. Adjusting for heritable covariates can bias effect estimates in genome-wide association studies. Am J Hum Genet. 2015 Feb 05; 96(2):329-39.
    View in: PubMed
    Score: 0.158
  8. Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. Am J Epidemiol. 2014 Nov 15; 180(10):1018-27.
    View in: PubMed
    Score: 0.154
  9. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study. BMJ. 2017 10 31; 359:j4761.
    View in: PubMed
    Score: 0.096
  10. Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. Int J Epidemiol. 2020 02 01; 49(1):259-269.
    View in: PubMed
    Score: 0.056
  11. Corrigendum to: Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies. Int J Epidemiol. 2020 02 01; 49(1):352.
    View in: PubMed
    Score: 0.056
  12. Shared heritability and functional enrichment across six solid cancers. Nat Commun. 2019 01 25; 10(1):431.
    View in: PubMed
    Score: 0.052
  13. Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. PLoS Med. 2018 09; 15(9):e1002644.
    View in: PubMed
    Score: 0.051
  14. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. JAMA Oncol. 2016 Oct 01; 2(10):1295-1302.
    View in: PubMed
    Score: 0.044
  15. Telomere structure and maintenance gene variants and risk of five cancer types. Int J Cancer. 2016 Dec 15; 139(12):2655-2670.
    View in: PubMed
    Score: 0.044
  16. A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2016 Jan; 25(1):193-200.
    View in: PubMed
    Score: 0.042
  17. Association of breast cancer risk loci with breast cancer survival. Int J Cancer. 2015 Dec 15; 137(12):2837-45.
    View in: PubMed
    Score: 0.041
  18. Genetic risk variants associated with in situ breast cancer. Breast Cancer Res. 2015 Jun 13; 17:82.
    View in: PubMed
    Score: 0.041
  19. Vitamin D-associated genetic variation and risk of breast cancer in the breast and prostate cancer cohort consortium (BPC3). Cancer Epidemiol Biomarkers Prev. 2015 Mar; 24(3):627-30.
    View in: PubMed
    Score: 0.039
  20. Testing calibration of risk models at extremes of disease risk. Biostatistics. 2015 Jan; 16(1):143-54.
    View in: PubMed
    Score: 0.038
  21. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. Hum Mol Genet. 2014 Oct 01; 23(19):5260-70.
    View in: PubMed
    Score: 0.038
  22. Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer. PLoS One. 2014; 9(3):e92212.
    View in: PubMed
    Score: 0.037
  23. Leveraging family history in population-based case-control association studies. Genet Epidemiol. 2014 Feb; 38(2):114-22.
    View in: PubMed
    Score: 0.037
  24. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet. 2013 Apr; 45(4):385-91, 391e1-2.
    View in: PubMed
    Score: 0.035
  25. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet. 2013 Jan 15; 22(2):408-15.
    View in: PubMed
    Score: 0.034
  26. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet. 2011 Jul 10; 43(8):785-91.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.